X-9027873-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_205849.3(FAM9B):c.487G>A(p.Val163Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000955 in 1,203,979 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 33 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_205849.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM9B | NM_205849.3 | c.487G>A | p.Val163Ile | missense_variant | 7/9 | ENST00000327220.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM9B | ENST00000327220.10 | c.487G>A | p.Val163Ile | missense_variant | 7/9 | 1 | NM_205849.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 111876Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34058
GnomAD3 exomes AF: 0.0000655 AC: 12AN: 183133Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67633
GnomAD4 exome AF: 0.0000943 AC: 103AN: 1092103Hom.: 0 Cov.: 28 AF XY: 0.0000810 AC XY: 29AN XY: 358051
GnomAD4 genome AF: 0.000107 AC: 12AN: 111876Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34058
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.487G>A (p.V163I) alteration is located in exon 6 (coding exon 6) of the FAM9B gene. This alteration results from a G to A substitution at nucleotide position 487, causing the valine (V) at amino acid position 163 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at